Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Hematopoietic activity of human short-term repopulating cells in mobilized peripheral blood cell transplants is restricted to the first 5 months after transplantation.

Zavidij O, Ball CR, Herbst F, Fessler S, Schmidt M, von Kalle C, Glimm H.

Blood. 2010 Jun 17;115(24):5023-5. doi: 10.1182/blood-2010-02-271528. Epub 2010 Apr 9.

2.

Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.

Hogan CJ, Shpall EJ, McNiece I, Keller G.

Biol Blood Marrow Transplant. 1997 Nov;3(5):236-46.

PMID:
9450918
3.

Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit.

Nauta AJ, Kruisselbrink AB, Lurvink E, Mulder A, Claas FH, Noort WA, Willemze R, Fibbe WE.

Exp Hematol. 2005 Oct;33(10):1249-56.

PMID:
16219548
4.

Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells.

Guenechea G, Segovia JC, Albella B, Lamana M, Ramírez M, Regidor C, Fernández MN, Bueren JA.

Blood. 1999 Feb 1;93(3):1097-105.

5.

Regulation of human short-term repopulating cell (STRC) engraftment in NOD/SCID mice by host CD122+ cells.

Shultz LD, Banuelos SJ, Leif J, Appel MC, Cunningham M, Ballen K, Burzenski L, Greiner DL.

Exp Hematol. 2003 Jun;31(6):551-8.

PMID:
12829032
6.
7.
8.

Ex vivo expansion of human adult stem cells capable of primary and secondary hemopoietic reconstitution.

Gammaitoni L, Bruno S, Sanavio F, Gunetti M, Kollet O, Cavalloni G, Falda M, Fagioli F, Lapidot T, Aglietta M, Piacibello W.

Exp Hematol. 2003 Mar;31(3):261-70.

PMID:
12644024
9.
10.

Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice.

Cashman JD, Lapidot T, Wang JC, Doedens M, Shultz LD, Lansdorp P, Dick JE, Eaves CJ.

Blood. 1997 Jun 15;89(12):4307-16.

11.

Conditions that enable human hematopoietic stem cell engraftment in all NOD-SCID mice.

Rice AM, Wood JA, Milross CG, Collins CJ, McCarthy NF, Vowels MR.

Transplantation. 2000 Mar 15;69(5):927-35.

PMID:
10755552
12.

Enrichment of human hematopoietic stem cell activity in the CD34+Thy-1+Lin- subpopulation from mobilized peripheral blood.

Murray L, Chen B, Galy A, Chen S, Tushinski R, Uchida N, Negrin R, Tricot G, Jagannath S, Vesole D, et al.

Blood. 1995 Jan 15;85(2):368-78.

13.

Quantity and quality of engrafting cells in cord blood and autologous mobilized peripheral blood.

Leung W, Ramírez M, Civin CI.

Biol Blood Marrow Transplant. 1999;5(2):69-76.

PMID:
10371358
14.
16.
17.

Preserved long-term repopulation and differentiation properties of hematopoietic grafts subjected to ex vivo expansion with stem cell factor and interleukin 11.

Albella B, Segovia JC, Guenechea G, Pragnell IB, Bueren JA.

Transplantation. 1999 May 27;67(10):1348-57.

PMID:
10360589
19.

The chemokine GRObeta mobilizes early hematopoietic stem cells characterized by enhanced homing and engraftment.

Fukuda S, Bian H, King AG, Pelus LM.

Blood. 2007 Aug 1;110(3):860-9. Epub 2007 Apr 6.

20.

Functional analysis of human hematopoietic repopulating cells mobilized with granulocyte colony-stimulating factor alone versus granulocyte colony-stimulating factor in combination with stem cell factor.

Hess DA, Levac KD, Karanu FN, Rosu-Myles M, White MJ, Gallacher L, Murdoch B, Keeney M, Ottowski P, Foley R, Chin-Yee I, Bhatia M.

Blood. 2002 Aug 1;100(3):869-78.

Supplemental Content

Support Center